Delivery Order SPE2DB25D3201-SPE2DB25FNTXL
Award Date
6/13/25
Potential Completion Date
6/16/25
Potential Value
$5.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of KANJINTI 420 MG VIALS. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $11,369.04 and a performance period that runs through May 23, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 420 mg vials of the drug KANJINTI. The contract has a firm fixed price of $18,948.40 and a completion date of June 26, 2025. The contract is not set aside and represents an open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $18,948.40, is for the supply of KANJINTI 420 MG VIALS, a specialty pharmaceutical product. The ultimate completion date for this delivery order is February 19, 2025. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,114.80, is for the delivery of Kanjinti 420 mg vials and has a completion date of February 26, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $433,759.17 and a period of performance through May 12, 2025. It is a firm-fixed-price contract for the delivery of pharmaceutical products and medical supplies to support military healthcare programs. The award is associated with Amerisourcebergen's larger Indefinite...
This is a delivery order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $5,111.65 and a completion date of December 2, 2024. It is a firm-fixed-price contract for the delivery of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $11,138.20 and a period of performance through May 29, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $11,549.78 and is a firm fixed-price delivery order, with an ultimate completion date of May 20, 2025. The contract is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00. This IDC...
This is a delivery order (SPE2DB20D3103|SPE2DB25FN4T3) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,944,134 units of KINEVAC 5 MCG VIALS. The award has a total ceiling value of $4,138.50 and is a firm fixed-price contract with an ultimate completion date of April 17, 2025. The contract is not set aside and was awarded on April 16, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,508.13 and a performance period through May 2025. It is a firm fixed-price contract for the delivery of various pharmaceutical and medical products, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The...